Experience the Future of Surgery
Das Spielen von Roulette mobil gratis ist eine fantastische Möglichkeit, tanzberglamas.de Ihre Lieblingscasinospiele zu genießen, ohne einen Cent auszugeben. In diesem Artikel werden wir die besten Online-Casinos für Roulette mobil gratis untersuchen und Ihnen alle wichtigen Informationen geben, die Sie benötigen,
Als erfahrener Spieler mit 14 Jahren Erfahrung in Online-Casinos war ich gespannt darauf, das neue Roulette-Turnier von Casino XYZ auszuprobieren. In diesem Artikel werde ich Ihnen alle Informationen über dieses aufregende neue Turnier geben, einschließlich Spielregeln, Teilnahmebedingungen, Tipps und Tricks sowie meine persönliche Meinung als langjähriger Spieler.
| Name | Lizenz | Unternehmen | Terretorien |
|---|---|---|---|
| Casino XYZ | MGA | XYZ Group | Europäische Länder |
Casino XYZ ist ein renommiertes Online-Casino, das eine Vielzahl von Spielen und Turnieren für seine Spieler anbietet. Mit einer Lizenz der Malta Gaming Authority können Spieler sicher sein, dass sie in einem seriösen und fairen Umfeld spielen. Das Casino ist in verschiedenen europäischen Ländern verfügbar und bietet eine Vielzahl von Zahlungsmethoden für Ein- und Auszahlungen.
Das Roulette-Turnier bei Casino XYZ bietet Spielern die Möglichkeit, ihr Können am Roulette-Tisch unter Beweis zu stellen und dabei attraktive Preise zu gewinnen. Das Turnier findet regelmäßig statt und die Teilnahmebedingungen sind einfach und klar. Spieler müssen eine Mindesteinsatzanforderung erfüllen und können dann am Turnier teilnehmen. Es gibt verschiedene Preise zu gewinnen, darunter Geldpreise, Freispiele und mehr.
| Gerät | Kompatibilität |
|---|---|
| Mobile | Ja |
| Desktop | Ja |
| Tablet | Ja |
| Pros | Cons |
|---|---|
| Attraktive Boni | Begrenzte Zahlungsmethoden |
| Vielfältige Spielauswahl | Keine 24/7 Kundensupport |
Um die Fairness des Spiels zu überprüfen, sollten Spieler darauf achten, dass das futuramasutra.de Casino eine gültige Lizenz besitzt, regelmäßig von unabhängigen Behörden überprüft wird und eine faire RNG-Software verwendet. Spieler können auch auf Bewertungen und Erfahrungen anderer Spieler zugreifen, um sicherzustellen, dass das Casino vertrauenswürdig ist.
Ich hoffe, dass dieser Artikel Ihnen alle Informationen liefert, die Sie über das neue Roulette-Turnier von Casino XYZ benötigen. Viel Glück und Spaß beim Spielen!
(Netanya, Israel) 6 June 2023 – Lankenau Medical Center and Dr. John Marks, internationally recognized for outstanding expertise and innovation in minimally invasive surgery, has acquired SURROUNDSCOPE™ from 270Surgical Ltd.
The SURROUNDSCOPE™, developed and manufactured by 270Surgical, is a pioneering laparoscopic system, enabling surgeons a new, safer, and more efficient way to operate.
The revolutionary 270 ̊ Surround Field of View technology reduces ‘off-screen’ injuries, provides surgeons unparalleled visibility, and has the potential to substantially improve patient outcomes.
“A 270-degree view is incredible and so much more than we see in laparoscopic and robotic surgery,” says Dr. Marks. “It’s even more than we can see in open surgery.”
“With a much better view of what’s all around the area where we’re operating – meaning no blind spots – we can avoid possible injury to tissues that are off screen,” Dr. Marks adds. “It’s just so much safer as well as more efficient, since we don’t need to move the laparoscope to see better.”
Additional benefits of the SURROUNDSCOPE™- the world’s first FDA Cleared 270-degree field-of-view laparoscope system are the prevention of fogging on the camera and the ability to see through smoke caused by tissue cauterization, both representing a tremendous advantage compared to standard laparoscopes available in the market.
“Standard laparoscopes have lenses that fog when inside the body,” says Dr. Marks. “When this happens, we need to pull the laparoscope out of the body, clear the lens and then put it back inside to continue. This might happen four or more times during an operation. Because this new device is designed to prevent fogging, we can keep the camera in the body without having to clear it, for a shorter operating time. It’s a huge benefit.”
Avi Levy, the inventor of SURROUNDSCOPE™ and CEO of 270Surgical commented: “We are very proud to have identified Lankenau Medical Center as a premier location for us to enter the U.S. Market. Dr. Marks is a visionary and globally respected surgeon who shares our passion for making surgery safer and more efficient for patients and surgeons, and to expand the use of MIS in the future for improved surgery outcomes and patients’ comfort.”
About Lankenau Medical Center
Lankenau Medical Center, part of Main Line Health, is a longtime teaching and research hospital. Lankenau Medical Center is ranked as one of the top 3 hospitals out of nearly 100 in the Philadelphia region and among the top 10 hospitals out of more than 200 in Pennsylvania.
About 270Surgical
Established in 2016, 270Surgical is a pioneering medical device company aiming to revolutionize Minimally Invasive Surgery with its pioneering visualization platform the SURROUNDSCOPE™ – the world’s first FDA Cleared 270-degree field-of-view laparoscope system.
For more information, please visit www.270Surgical.com.
Contact:
Chad Croasdale
President and CCO
Netanya, Israel and Dallas TX – April 20, 2023 – We are thrilled to share 270Surgical has been extended a prestigious invitation to participate in the MedTech Innovator pitch event in Dublin. This event serves as a platform to showcase groundbreaking advancements and connect with industry leaders, solidifying 270Surgical’s position as a trailblazer in the medical technology sector.
A Spotlight on Innovation MedTech Innovator, renowned for its commitment to fostering innovation in healthcare, has handpicked 270Surgical to join an elite group of cutting-edge companies at their upcoming pitch event in Dublin. This invitation is a testament to 270Surgical’s dedication to pushing the boundaries of surgical solutions and revolutionizing patient care.
Netanya, Israel and Dallas TX – April 3, 2023 – 270Surgical Ltd. (the “Company”) returned to SAGES with the latest version of the SURROUNDSCOPE, the world’s most advanced FDA Cleared laparoscopic system on the market.
The Surgical Association for Gastrointestinal Endoscopy Surgeons (SAGES) 2023 conference held in Montreal was an extraordinary gathering of the finest minds in surgical innovation. Esteemed surgeons from across North America were able to experience the novel technology and unique concept firsthand. The atmosphere was electric with excitement as world-leading surgeons acknowledged its potential to revolutionize the future of surgery.
“Seeing better is doing better, and this really allows you to do that, and if you are seeing better you are going to have a safer outcome.” Dr. John Marks, Chief of Colorectal Surgery at Lankenau Medical Center.
Dr John Marks’ testimonial at SAGES 2023
A New Era in Laparoscopy
The SURROUNDSCOPE is a game-changer in the realm of laparoscopic surgery, offering unparalleled precision, visualization, and control. Designed to enhance surgeon dexterity and patient outcomes, this revolutionary system leverages cutting-edge technology to provide a truly immersive and intuitive experience for surgeons.
SAGES 2023 provided the perfect platform for 270Surgical to demonstrate the capabilities of their laparoscopic system. Attendees were enthralled as world-renowned surgeons such as Dr. Santiago Horgan (UCSD), Dr. John Marks (Lankenau Medical Center) and Dr. Gideon Sroka (Bnai-Zion Medical Center) showed the advanced features and discussed their experiences using this state-of-the-art technology. Surgeons were particularly excited about the novel concept of the system, which offers a 270-degree view of the surgical field, allowing for enhanced spatial awareness and precise maneuvering, resulting in increased safety as well as shorter surgery time.
270Surgical’s SurroundScope was presented by Dr. Yoav Mintz, the Chair of the European Association for Endoscopic Surgery (EAES) Technology Committee, at the European Association for Endoscopic Surgery in Barcelona.
Dr. Mintz presented the “SurroundScope” – our 270 field of view endoscopic system, at the ‘Surgical technologies in the near future’ session and reported he had nothing to disclose.
Dr. Yoav Mintz is an associate professor of surgery and director of the division of foregut surgery at Hadassah Medical Center, Jerusalem, Israel.
The recording of the EAES Winter Meeting 2022, ‘Surgical technologies in the near future – Wide view laparoscopic camera’ is available on demand. Free access for EAES members.
270Surgical Ltd. Receives FDA Clearance
270Surgical Ltd. Receives FDA Clearance
Netanya, Israel and Dallas TX – August 20, 2021 – 270Surgical Ltd. (the “Company”) announces a new publication at the prestigious Surgical Endoscopy Journal, highlighting the company’s ground-breaking visualization system, the SURROUNDSCOPE, and its potential to revolutionize the field by improving visualization, enhancing patient safety, and reducing procedure duration.
Making Strides in Laparoscopy
270Surgical’s publication in the Surgical Endoscopy Journal signifies a significant leap forward in the field of laparoscopic surgery. The study titled “The Introduction of Wide-Angle 270° Laparoscopy through a Novel Laparoscopic Camera System” showcases the company’s pioneering laparoscopic technology and its potential to transform surgical procedures.
A Revolutionary Camera System
The core innovation at the heart of 270Surgical’s laparoscopic system is the SURROUNDSCOPE camera. Traditionally, laparoscopic surgery has been limited by a narrow field of view (FOV) of 70°. This constrained perspective can result in complications and compromised visualization during procedures. However, the SURROUNDSCOPE system takes a bold leap by expanding the FOV to an impressive 270°. Achieved through the integration of side cameras at the distal tip of the laparoscope, this expanded FOV opens up new possibilities for surgeons.
In addition to the expanded FOV, 270Surgical’s system addresses two common obstacles encountered in laparoscopic surgery: fogging and smoke accumulation. The SURROUNDSCOPE’s innovative technology and advanced LED illumination eliminates fogging, ensuring optimal visualization throughout the procedure. Moreover, the impact of smoke is greatly reduced, alleviating the need for laparoscope removal or venting, and allowing surgeons to maintain clear visualization without interruption.
Positive Initial Clinical Experience
The publication outlines the promising results obtained during the initial clinical experience with the SURROUNDSCOPE. Thirty-seven laparoscopic surgeries were performed, with all procedures completed successfully and without adverse events. Surgeons and camera holders provided valuable feedback, highlighting the system’s advantages over traditional laparoscopy.
Surgeons reported improved visualization, as the SURROUNDSCOPE system allowed them to track surgical tools from the port to the surgical site without the need for constant camera manipulation. The expanded FOV also enabled the identification of potentially adverse events occurring outside the central frame, further enhancing patient safety.
As the medical community eagerly awaits further research and quantification of the system’s benefits, the publication serves as a testament to the dedication of 270Surgical in developing innovative solutions that advance surgical techniques.
Conclusion
The inclusion of 270Surgical’s journal publication in the esteemed Surgical Endoscopy Journal is a testament to the transformative potential of their laparoscopic system. With its expanded FOV, elimination of fogging, and reduced impact of smoke, the SurroundScope system has the potential to reshape the future of laparoscopic surgery. This pioneering technology brings hope for improved surgical outcomes, setting the stage for a new era of precision and innovation in the operating room.
Netanya, Israel and Dallas TX – February 6, 2020 – 270Surgical Ltd. (the “Company”) announced today that an abstract featuring new data for its SurroundScope System was selected for a podium presentation at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting, which is taking place from April 1st – 4th at the Huntington Convention Center in Cleveland, OH.
Podium Presentation Details:
Title: SurroundScope – The introduction of wide-angle 270-degree laparoscopy
Conf. Session: Emerging Technology Session
Date and Time: 10:00 a.m. to 12:00 p.m. ET on Thursday, April 2nd
About the SurroundScope System
The SurroundScope System consists of a hardware, software and electro-optic solution that incorporates a myriad of lenses at the distal end of the scope. The result is a specialty laparoscopic system that addresses three long-standing challenges in laparoscopy, including restricted field-of-view, surgical smoke (plume), and lens fogging. The SurroundScope is the first marketable laparoscope that offers up to a 270-degree field-of-view, which is an increase of 200% compared to other laparoscopes in the market. This expanded field-of-view is expected to have considerable implications for procedures performed within the disciplines of general surgery, trauma, OBGYN, and thoracic surgery.
About 270Surgical Ltd.
Founded in 2016, 270Surgical is a medical device company that developed the SurroundScope System, an innovative laparoscopic camera system. The SurroundScope System is the first laparoscopic system to offer a 270-degree field-of-view. The SurroundScope received FDA clearance in November 2019, and is expected to be commercially available in the U.S. in the second half of 2020. For more information, please visit www.270Surgical.com.
Scott is a successful Medtech CEO, Chairperson, board member, entrepreneur, and investor, having been involved in one of those roles in 20+ startup, growth and public companies with market valuations that have totaled over $20b and more importantly over 20 million patients that have benefited from the therapies & diagnostics of these companies, including 8 IPOs. Current professional affiliations include Principal Front Foot Ventures, Chairperson Hyperfine (HYPR) IPO 2021, Chairperson Acutus Medical (AFIB) IPO 2020, Chairperson Envista (NVST) IPO 2019, Board Member Nuvasive (NUVA), Exec Chairperson & Investor Elucid, Exec Chairperson & Investor Wondr Medical, Chairperson & Investor Kardion, Board member & Investor, Q’apel Medical, Board member & Investor Proximie, Board member & Investor Foldax, Board Member Veranex Solutions, Advisor & Investor Genesis Healthcare, Advisor & Investor Cortica, advisor Brightinsight, Board Member & past Chairperson Medical Device Manufacturer’s Association (MDMA), and advisor to Peloton Equity, 8VC, River Cities Capital and Accelmed Equity. He completed his role as Pres & CEO of Verb Surgical in early 2019. Verb was Google & J&J’s Surgical Robotics and Digital Surgery platform start-up to revolutionize the future of surgery which J&J acquired in 2019. Previously, Scott led Volcano Corp. (VOLC), a leader in minimally invasive therapy guidance in interventional cardiology, as its first & only Pres & CEO, from start-up in 2002 to its IPO in 2006 and sale to Philips in 2015. Volcano 2014 revenue was > $400 million and its market capitalization peaked at nearly $2B. Prior to this, he was at Digirad Corp, a coronary imaging solutions provider, from 1997 to 2002, as President & CEO. Digirad went public in 2004 (DRAD).
Didi is an experienced business development specialist and entrepreneur, specializing in international B2B/G2G business opportunities, capital raising and partnerships.
Didi serves as a Business Development consultant to several companies including Mekorot, Vital OP, Bnai Zion Medical Center, Aster Medical (Dubai) and more, as well as operates international business initiatives with a focus on the GCC countries and Azerbaijan.
Currently Didi is a Board Member at Israel Bonds and has previously founded and managed several successful small businesses including Goldfish Production and CrossFit Haifa.
Didi holds an HBA (Business Administration) from Western University, Canada, with distinction.
Ariel is a leading expert in corporate finance and venture capital financing.
He is the managing Partner and CFO of Agate Venture Capital group. Ariel has extensive experience in leading MedTech investments, corporate finance and fund management. Experienced in managing portfolio investments.
He is currently a Board member at 270 Surgical, Clew Medical, ForSight Vision 6, BrainsGate and Rapid.
Former Co-Founder & CEO of a FinTech startup company.
Ariel holds a B.A in economics from the Hebrew University of Jerusalem and a LLB from Uno Academic College.
Mike has over 30 years of leadership, business and technology management experience in the health arena.
Throughout his 24 years at Teva Pharmaceuticals Industries, from Key Account Manager to CEO of Teva-Israel and up to Head of Global Innovative Products Division.
Mike holds a B.A.in Economics and Business Administration and M.B.A. in Marketing and International Management from Tel Aviv University, and is a graduate of senior global management courses at INSEAD and Israel Institute of Technology (TIM)
Mike serve as a Member of the BioMed investment committee at Club 100 Plus Angels, investing and board member of several start-ups in the health arena.
Dennis has over 35 years experience in the medical device industry with focus on GI, Endoscopy, Surgery and Cardiology. His diversified experience includes General Manager of Conmed Corp GI Endoscopy plus VP positions in Marketing, Finance and Manufacturing with Bard. He is also the co-founder and COO of 4 Medical Device start-ups and consults for a number of others in the area of Strategic Business and Product Development.
Dennis started his career with KPMG and has as a BS in Accounting and MBA in Marketing.
Santiago Horgan, MD, is Chief, Minimally Invasive Surgery Director, Bariatric and Metabolic Institute Director in UCSD. He is an internationally recognized expert in esophageal disease, weight-loss surgery, minimally invasive surgery and new technologies and approaches for surgery.
Dr. Jon I. Einarsson, MD, MPH, Chief, Division of Minimally Invasive Gynecology, Professor, Harvard Medical School
Dr. Severson is the Co-Director of the Minnesota Institute for Minimally Invasive Surgery and the Program Director of the MIMIS Fellowship in Advanced GI MIS, Bariatric Surgery and Flexible Endoscopy. Dr. Paul Severson is the medical director for and a reflux specialist with the Minnesota Reflux and Heartburn Center at Riverwood Healthcare Center in Aitkin and Cuyuna Regional Medical Center in Crosby.
Avi has over 20 years of experience in the Medical Device industry and has successfully managed Operations, Production and Logistics teams in Medical Device organizations.
Avi holds a BSc from Ben Gurion University and an MA degree in Industrial Management from Bar Ilan University.
Guy is a Certified Public Accountant, with over 20 years of experience in accountancy, tax and financial management. He spent 3 years at Deloitte prior to opening a boutique accounting firm which employs 15 professionals comprised of CPAs, tax consultants and bookkeepers.
Guy has served as CFO in medical devices companies under the management of Avraham Levy (Peer Medical Ltd, 270 Surgical Ltd) since 2009.
Mr. Blair is a 1997 graduate of the Business Management School of the College for Management , and obtained his Israeli Certified Public Accountants License in 1999.
Golan brings more than 19 years of R&D experience in medical devices with a heavy emphasis in the Endoscopy field and Opto-mechanical design. He has managed multi-disciplinary global R&D and engineering teams for more than 13 years for start-ups and large companies including Endochoice, and Stryker. Golan was also Co-founder of Peer Medical prior to it merging with Endochoice.
Golan holds a degree in Mechanical Engineering from the Naval Officers School of Acre.
Ari is a veteran executive, investor and board director with over 18 years of experience in the start-up industry. He is spearheading the fundraising and business development efforts for 270Surgical. Ari is the founder and managing director of Cider Investments, a family office with investments in biotech, med-tech, agri-tech, hi-tech, as well as in venture capital funds. In addition to 270Surgical, Ari has served in executive roles at Biowise, Triventures, Johnson & Johnson Development Corporation, and Ernst & Young, Israel.
Ari earned a degree in B.S. in Biology and Physics from the University of Toronto.
Moshe has over 15 years of experience in medical device R&D, predominantly within the field of Endoscopy. He has successfully managed multi-disciplinary global R&D and engineering teams for companies including Stryker, Angioslide and Endochoice. He has relevant experience leading teams of people in mechanical engineering, software development and optics as has developed vast valuable expertise within medical device regulation.
Moshe holds a B.S. in mechanical engineering from Ben-Gurion University of the Negev.
Dr. Shapira has honed her expertise in Endoscopic Clinical Trials over 15 years of experience in the industry. Prior to 270Surgical she directed the clinical trials for Motus GI, MetaCure, and Stryker Israel. In addition, she served as a consultant for clinical trials in various companies, gaining an experience in a variety of therapeutic area including Endoscopy, Diabetes, Glaucoma, Acute Decompensated Heart Failure (ADHF), Stuttering, Thoracic Fluid, Thrombectomy, Dysmenorrhea (menstrual pain) and Alopecia (hair loss).
Dr. Shapira holds a PhD in Biomedical Engineering, from the Technion, Israel.
Chad brings more than 20 years of experience in HealthCare and Medical Devices. He has 10 years of Full P&L Management at Stryker where he served at VP & General Manager for the Communications Business Unit, one of the fastest growing businesses at Stryker. In this capacity, he served as a member of the Commercial Steering Committee for Stryker Endoscopy, a powerhouse in the rigid Endoscopic Market. He brings relevant expertise in the commercialization of products, market strategy and operational execution. Prior to joining Stryker, Chad was a clinician / center-manager for NovaCare, an outpatient provider of Physical and Occupational Therapy.
Croasdale holds a B.A. from Hobart College (Psychology), and a M.S. from Widener University (Physical Therapy).
Avi Levy is the CEO and Founder of 270Surgical. For the past three decades, Avi has had tremendous success as an inventor, entrepreneur, investor, and a high-level executive within the Med-Device and Telecommunication industries.
In 2010 was the founder and CEO of Peer Medical which developed an innovative colonoscopy system. While at Peer, Avi spearheaded a merger with Endochoice, and helped take the collective companies public (Endochoice, NYSE: GI).
Prior to Peer Medical, Mr. Levy was appointed as the CEO of Sightline Technologies, which developed a comprehensive disposable solution for colonoscopy. Mr. Levy led an acquisition by Stryker for $150M. Mr. Levy continued for 3 years as VP of R&D and GM of Stryker Israel for 3 years and established an innovation center of 80 employees in Israel.
Avi holds a dual degree in Mathematics and Physics from the Hebrew University, a Mechanical Practical Engineering Degree from ORT Jerusalem and a Business Management certification from Bar-Ilan University.
Avi Levy is the CEO and Founder of 270Surgical. For the past three decades, Avi has had tremendous success as an inventor, entrepreneur, investor, and a high-level executive within the Med-Device and Telecommunication industries.
In 2010 was the founder and CEO of Peer Medical which developed an innovative colonoscopy system. While at Peer, Avi spearheaded a merger with Endochoice, and helped take the collective companies public (Endochoice, NYSE: GI).
Prior to Peer Medical, Mr. Levy was appointed as the CEO of Sightline Technologies, which developed a comprehensive disposable solution for colonoscopy. Mr. Levy led an acquisition by Stryker for $150M. Mr. Levy continued for 3 years as VP of R&D and GM of Stryker Israel for 3 years and established an innovation center of 80 employees in Israel.
Avi holds a dual degree in Mathematics and Physics from the Hebrew University, a Mechanical Practical Engineering Degree from ORT Jerusalem and a Business Management certification from Bar-Ilan University.
